Results 271 to 280 of about 1,089,521 (397)

Three‐Year Follow‐Up of Neoadjuvant Tislelizumab with Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Adenocarcinoma: Revealing Cancer‐Associated Fibroblast Heterogeneity Corresponding to PD‐1 Blockade Efficacy

Advanced Science, EarlyView.
Heterogeneous cancer‐associated fibroblasts orchestrate dual immune microenvironments in LAGC. Abstract The potential for immunotherapy in patients with locally advanced gastric cancer (LAGC) is recently confirmed. To report the 3‐year follow‐up data are aimed from a novel clinical trial. This is a prospective single‐arm phase II trial.
Yao Lin, Xiong Sun, Chengguo Li, Ming Yang, Ke Wu, Ke Liu, Anshu Li, Xiaoming Shuai, Kailin Cai, Zheng Wang, Guobin Wang, Peng Zhang, Jianfeng Shen, Kaixiong Tao, Yuping Yin   +14 more
wiley   +1 more source

Increased platelet aggregation in hepatic tissue of metabolic-associated fatty liver disease-an observational study. [PDF]

Front Med (Lausanne)
Fan R, Li Y, Du Z.
europepmc   +1 more source

Adenosine Diphosphate–Induced Platelet Aggregation Is Associated With P2Y12 Gene Sequence Variations in Healthy Subjects

Circulation, 2003
P. Fontana, A. Dupont, S. Gandrille, C. Bachelot-Loza, J. Reny, M. Aiach, P. Gaussem   +6 more
semanticscholar   +1 more source

Inhibitory mechanism of ristocetin-induced platelet aggregation by IgG1(.LAMBDA.) M component.

, 1985
Haruo Nakamura
openalex   +2 more sources

Expandable Nanocomposite Shape‐Memory Hemostat for the Treatment of Noncompressible Hemorrhage

Advanced Science, EarlyView.
A nanocomposite‐coated shape memory foam rapidly expands, accelerates clotting, and reduces blood loss in vivo. Its fast volumetric expansion and strong procoagulant activity make it a promising hemostat for treating deep, noncompressible hemorrhage.
Saptarshi Biswas, Sarah E. Miller, Shounak Roy, Jeevika Thazhaiselvam, Samantha Foster, Manivannan Sivaperuman Kalairaj, Sasha M. George, Yava Jones‐Hall, Staci J. Horn, Fred J. Clubb, Taylor H. Ware, Duncan J. Maitland, Akhilesh K. Gaharwar   +12 more
wiley   +1 more source

Anti-Thrombotic Activity of 3-Deoxysappanchalcone via Inhibiting Platelet Aggregation and Thrombin (FIIa)/Activated Factor X (FXa) Activity. [PDF]

Molecules
Han G, Lee J, Bae JS.
europepmc   +1 more source

Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice.

Journal of Clinical Investigation, 1999
C. Léon, B. Hechler, M. Freund, A. Eckly, C. Vial, P. Ohlmann, A. Dierich, M. Lemeur, J. Cazenave, C. Gachet   +9 more
semanticscholar   +1 more source

Extracellular Vesicle‐Delivered tRF‐His‐GTG‐1 Reprograms Neutrophil Lipophagy and Triggers Inflammation in COVID‐19

Advanced Science, EarlyView.
This study identifies platelet‐derived extracellular vesicles as key immunometabolic regulators in COVID‐19. The delivery of tRF‐His‐GTG‐1 to neutrophils activates TLR8mTOR signaling, disrupts lipophagy, and amplifies NET‐mediated inflammation. Importantly, targeting this axis restores neutrophil homeostasis, offering a potential therapeutic strategy ...
Tsai‐Ling Liao, Po‐Yu Liu, Yi‐Ming Chen, Kuo‐Tung Tang, Hung‐Jen Liu, Der‐Yuan Chen   +5 more
wiley   +1 more source

Obstructive Sleep Apnea, Platelet Aggregation, and Cardiovascular Risk. [PDF]

J Am Heart Assoc
Kovbasyuk Z, Ramos-Cejudo J, Parekh A, Bubu OM, Ayappa IA, Varga AW, Chen MH, Johnson AD, Gutierrez-Jimenez E, Rapoport DM, Osorio RS.   +10 more
europepmc   +1 more source

Effect of heparin and heparin fractions on platelet aggregation.

Journal of Clinical Investigation, 1980
E. Salzman, R. Rosenberg, M. Smith, J. Lindon, L. Favreau   +4 more
semanticscholar   +1 more source